Status:
TERMINATED
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Lead Sponsor:
Hartford Hospital
Collaborating Sponsors:
Neuronetics
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We are investigating the feasibility and efficacy of transcranial magnetic stimulation (TMS) for patients with GAD who were placebo nonresponders in DIEF003523.1.
Detailed Description
We expected to enroll five patients with GAD who failed to respond to a sham (placebo) TMS intervention. In this pilot study we enrolled three participants into a protocol including 10 rTMS sessions (...
Eligibility Criteria
Inclusion
- Participated in the study DIEF003523.1, received sham "placebo" TMS and achieved \< 50% improvement in HARS at 3 month follow-up.
- Fluency in English
- Capacity to understand the nature of the study and willingness to sign informed consent form
Exclusion
- History of epilepsy or head trauma (LOC \> 5 minutes) within the past 6 months
- Lifetime history of increased intracranial pressure, seizure disorder, stroke, brain tumor, multiple sclerosis, or brain surgery
- A review of patient medications by the study physician indicates an increased risk of seizure
- An active autoimmune, endocrine, viral, or vascular disorder affecting the brain; any unstable cardiac disease; hypertension; or severe renal or liver insufficiency
- Substance use disorder or PTSD within the past 6 months
- Lifetime bipolar disorder, obsessive-compulsive disorder (OCD), psychotic disorder, mental retardation, or pervasive developmental disorder
- Any psychotic features, including dementia or delirium
- Concurrent psychotherapy and unwillingness to discontinue
- Medication change within the past 4 weeks
- Current serious suicidal or homicidal ideation, and/or serious suicidal attempt within the past 6 months
- Serious, unstable, or terminal medical condition or clinically judged too psychiatrically unstable to participate in the study
- Any contraindication for participation in MRI scan
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01815099
Start Date
May 1 2014
End Date
August 1 2015
Last Update
April 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06106